BEGIN:VCALENDAR
VERSION:2.0
METHOD:PUBLISH
CALSCALE:GREGORIAN
PRODID:-//WordPress - MECv6.5.5//EN
X-ORIGINAL-URL:https://compliance-calendar.sakiyomi.co.jp/
X-WR-CALNAME:Compliance Calendar
X-WR-CALDESC:
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-PUBLISHED-TTL:PT1H
X-MS-OLK-FORCEINSPECTOROPEN:TRUE
BEGIN:VEVENT
CLASS:PUBLIC
DTSTART;TZID=Asia/Tokyo:20220706T000000
DTEND;TZID=Asia/Tokyo:20220707T000000
DTSTAMP:20220711T000000
UID:MEC-03b92cd507ff5870df0db7f074728830@compliance-calendar.sakiyomi.co.jp
CREATED:20220712
LAST-MODIFIED:20220712
PRIORITY:5
TRANSP:OPAQUE
SUMMARY:米国｜規制薬物のスケジュール4-ヒドロキシ-N,N-ジイソプロピルトリプタミン（4-OH-DiPT）、5-メトキシ-α-メチルトリプタミン（5-MeO-AMT）、5-メトキシ-N-メチル-N- イソプロピルトリプタミンのスケジュールIへの収載と公聴会のお知らせ
DESCRIPTION:\nSchedules of Controlled Substances: Placement of 4-hydroxy-N,N-diisopropyltryptamine (4-OH-DiPT), 5-methoxy-alpha-methyltryptamine (5-MeO-AMT), 5-methoxy-N-methyl-N-isopropyltryptamine (5-MeO-MiPT), 5-methoxy-N,N-diethyltryptamine (5-MeO-DET), and N,N-diisopropyltryptamine (DiPT) in Schedule I; Announcement of Hearing ( https://www.federalregister.gov/documents/2022/07/06/2022-14372/schedules-of-controlled-substances-placement-of-4-hydroxy-nn-diisopropyltryptamine-4-oh-dipt )\n
URL:https://compliance-calendar.sakiyomi.co.jp/events/%e7%b1%b3%e5%9b%bd%ef%bd%9c%e8%a6%8f%e5%88%b6%e8%96%ac%e7%89%a9%e3%81%ae%e3%82%b9%e3%82%b1%e3%82%b8%e3%83%a5%e3%83%bc%e3%83%ab4-%e3%83%92%e3%83%89%e3%83%ad%e3%82%ad%e3%82%b7-nn-%e3%82%b8%e3%82%a4/
CATEGORIES:セクター,化学物質,医療・医薬品,医薬品
ATTACH;FMTTYPE=image/png:https://compliance-calendar.sakiyomi.co.jp/wp-content/uploads/2022/04/wide-medical-150x150-1.png
END:VEVENT
END:VCALENDAR